Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edgio, Inc. - Common Stock (NQ: EGIO )

0.7602 +0.0102 (+1.36%)
Streaming Delayed Price Updated: 10:39 AM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edgio, Inc. - Common Stock

< Previous 1 2 3 Next >
VEON, Rocket Lab And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday! 
Via InvestorPlace
Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher
U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Edgio Stock Plunged Today
Shares of the content delivery network tumbled on weak guidance. 
Via The Motley Fool
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's... 
Via Benzinga
Nasdaq Surges 600 Points; Gold Gains 2%
U.S. stocks traded sharply higher midway through trading , with the Nasdaq Composite gaining 600 points on Thursday. 
Via Benzinga
Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Dow Jumps Over 700 Points; US Inflation Rate Falls In October
U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Upgrades 
Via Benzinga
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11. 
Via Benzinga
D.R. Horton To $84? Plus This Analyst Slashes PT On CEVA By 25%
  Raymond James boosted the price target on D.R. Horton, Inc. (NYSE: DHI) from $77 to $84. D.R. Horton shares rose 1.2% to $76.38 in pre-market trading. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Thursday! 
Via InvestorPlace
Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 34.7% to $0.0858 in pre-market trading after gaining over 12% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, trader! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares! 
Via InvestorPlace
Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket
Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday. 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! It's time for another look at the biggest pre-market stock movers as we see why shares are moving Wednesday morning! 
Via InvestorPlace
Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket
Gainers Biophytis S.A. (NASDAQ: BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
11 Information Technology Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.